Atlas Trials

Absorption, Metabolism, Excretion, and the Determination of Absolute Bioavailability of Niraparib in Subjects With Cancer

Clinical trial NCT02476552 · COMPLETED

Trial details

NCT number
NCT02476552
Sponsor
Tesaro, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2015-02-01
Primary completion
2015-12-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.